Previous attempts to treat Christine’s Chronic Lymphocytic Leukemia (CLL) had failed. She participated in a clinical trial and subsequently went through a CAR T-cell transplant at the NCI-designated Fred & Pamela Buffett Cancer Center.
The Fred & Pamela Buffett Cancer Center is a recognized leader in cellular therapies such as stem cell transplants, bone marrow transplants and CAR T-cell therapy, treatments that harness the body’s own cells to fight cancer.
Kathy Folk never expected to become a medical pioneer. But 13 years after her cancer diagnosis, Folk made history as Nebraska’s first outpatient CAR T-cell therapy patient.
Jan Janisch-Hanzlik had been having strange symptoms for several years, was diagnosed with MS, and referred to Rana Zabad, MD. Dr. Zabad offered her a new option: enrollment in a first-of-its-kind clinical trial using allogeneic CAR T-cell therapy.
Chimeric antigen receptor T-cell therapy, or CAR T-cell therapy, is an innovative and promising treatment approach that has revolutionized the field of cancer therapy.
When Scott and Teresa Hueber celebrated their 40th wedding anniversary this past summer, it was much more than a celebration of marriage. It was also a celebration of life.
After traditional therapies weren't effective, lymphoma patient Nick Howe was one of our first patients to take part in a clinical trial for CAR T-cell therapy.
You’re about to leave the Nebraska Medicine website. The other site may collect information about your visit, including your IP address. Do you want to continue?
